11 Results for "

CNV

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "CNV" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-118530
CAS No.: 65002-17-7
Purity:  98.87%
Synonyms: SA96; Thiobutarit
Target:  

VEGFR

Bucillamine (SA96) is an orally active and potent sulfhydryl donor and antioxidant. Bucillamine is also an antirheumatic agent with antiangiogenic properties. Bucillamine can protect against Ischemia/reperfusion (I/R) injury in high-risk organ transplants. Bucillamine inhibits the production of VEGF. Bucillamine can be used for the research of choroidal neovascularization (CNV) and rheumatoid arthritis (RA) .
loading...
    loading...
Cat. No.: HY-12796
CAS No.: 934240-30-9
Purity:  99.85%
Synonyms: Vixotrigine; GSK-1014802; CNV1014802
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Raxatrigine (GSK-1014802) is a novel small molecule state-dependent sodium channel blocker; Nav1.7 sodium channel inhibitor.
loading...
    loading...
Cat. No.: HY-12796A
CAS No.: 934240-31-0
Purity:  98.94%
Synonyms: Vixotrigine hydrochloride; GSK-1014802 hydrochloride; CNV1014802 hydrochloride
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Raxatrigine hydrochloride (GSK-1014802 hydrochloride) is a novel small molecule state-dependent sodium channel blocker; Nav1.7 sodium channel inhibitor.
loading...
    loading...
Cat. No.: HY-132126
CAS No.: 848057-98-7
Purity:  99.87%
Target:  

SRPK

Research Areas:  

Others

SPHINX is a selective SRPK1 inhibitor with an IC50 value of 0.58 μM. SPHINX effectively reduces Choroidal Neovascularization (CNV) in vivo. SPHINX can be used for the research of (age-related macular degenaration) AMD .
loading...
    loading...
Cat. No.: HY-101990
CAS No.: 1031206-36-6
Purity:  99.81%
Target:  

VEGFR

Research Areas:  

Others

IMS2186 is an anti-choroidal neovascularization (CNV) agent that inhibits angiogenesis upstream of VEGF. IMS2186 can arrest cancer cell cycle in G2/M phase, thus exerting anti-proliferation and anti-angiogenesis effects. IMS2186 has no intraocular toxicity and reduces the amount of eye leakage and diseased cells .
loading...
    loading...
Cat. No.: HY-175556
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

CNV-dopamine is a photoreleasable D2 receptor-selective agonist. CNV-dopamine activates D2 receptors and induces G protein-coupled inwardly rectifying potassium (GIRK) currents. CNV-dopamine is promising for research of disorders like Parkinson’s disease and addiction .
loading...
    loading...
Cat. No.: HY-118530R
CAS No.: 65002-17-7
Synonyms: SA96 (Standard); Thiobutarit (Standard)
Bucillamine (Standard) is the analytical standard of Bucillamine. This product is intended for research and analytical applications. Bucillamine (SA96) is an orally active and potent sulfhydryl donor and antioxidant. Bucillamine is also an antirheumatic agent with antiangiogenic properties. Bucillamine can protect against Ischemia/reperfusion (I/R) injury in high-risk organ transplants. Bucillamine inhibits the production of VEGF. Bucillamine can be used for the research of choroidal neovascularization (CNV) and rheumatoid arthritis (RA) .
loading...
    loading...
Cat. No.: HY-P991310
CAS No.: 1253114-37-2
Synonyms: LT3015; LT-3000

Target:  

LPL Receptor

Research Areas:  

Neurological Disease Cancer

Lpathomab (LT3015; LT-3000) is a human IgG1 monoclonal antibody (mAb) targeting LPA. Lpathomab reduces the release of IL-8 and IL-6 cytokines in SKOV3 cells and blocks LPA-triggered tumor cell migration. Lpathomab reduces neovascularization in Matrigel plug and CNV models. Lpathomab inhibits brain injury in the CCI mouse model. Lpathomab can be used in the study of brain injury, ovarian cancer, diabetic neuropathy, and spinal cord injury. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001) .
loading...
    loading...
Cat. No.: HY-176993
CAS No.: 1995864-97-5
2-Et-AZT is a modified Azidothymidine (HY-17413). 2-Et-AZT inhibits caspase-1 activation. 2-Et-AZT reduces choroidal neovascularization (CNV) volume .
loading...
    loading...
Cat. No.: HY-187718
CAS No.: 304911-08-8
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

CGC-11150 is a decamine-based polyamine analog that acts as a voltage-dependent pore blocker of Kir channels. CGC-11150 produces voltage-dependent pore block similar to that of Spermine (HY-B1777) in recombinant Kir6.2 [N160D, L164C, C166S, Δ36] + SUR1 channels, but with faster on and off rates. CGC-11150 inhibits the development of and induces regression of laser-induced choroidal neovascularization (CNV). CGC-11150 is used in studies related to choroidal neovascularization .
loading...
    loading...
Cat. No.: HY-182372
CAS No.: 1638153-78-2
Target:  

Epoxide Hydrolase

Research Areas:  

Neurological Disease

SH-11037 is a potent inhibitor of soluble epoxide hydrolase (sEH) and docks to the substrate binding cleft in the sEH hydrolase domain. SH-11037 dose-dependently suppresses angiogenesis in the choroidal sprouting assay ex vivo and inhibited ocular developmental angiogenesis in zebrafish larvae. SH-11037 reduces choroidal neovascularisation lesion volume in the laser-induced CNV mouse model. SH-11037 synergises with anti-VEGF treatments in vitro and in vivo. SH-11037 induces G2/M phase blockade and retains retinal endothelial cell viability at active concentrations without overt toxicity. SH-11037 can be used for the research of retinal neovascularization and ocular neovascularization .
loading...
    loading...
  • 1